Search Within

Population Sciences Research Program

  1. "Nursing"
  2. "Center for Hematologic Malignancies"
  3. "Miguel-Angel Perales"
  4. "Survivorship Research"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (6)
  3. Research Letter (1)
Groups
  1. Bone Marrow Transplant (14)
  2. Center for Hematologic Malignancies (14)
  3. Department of Medicine (14)
  4. Hematologic Malignancies, Division of (14)
  5. Nursing (14)
  6. Survivorship Research (14)

More Groups

People
  1. Miguel-Angel Perales (14)
  2. Craig Sauter (11)
  3. Maria Palomba (10)
  4. Sergio Giralt (9)
  5. Anas Younes (8)
  6. Gunjan Shah (8)

More People

Years
  1. 2022 (1)
  2. 2021 (2)
  3. 2020 (3)
  4. 2019 (3)
  5. 2018 (1)
  6. 2017 (2)

More Years

Publications
  1. Blood (4)
  2. Haematologica (2)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Blood Advances (1)
  5. Hematological Oncology (1)
  6. Journal of Palliative Medicine (1)

More Publications

Publishers
  1. American Society of Hematology (5)
  2. Elsevier Inc. (2)
  3. Elsevier Science, Inc. (2)
  4. Ferrata Storti Foundation (2)
  5. Mary Ann Liebert, Inc (1)
  6. Taylor & Francis Group (1)

More Publishers

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pilot trial of homebound hematopoietic cell transplantation
    Journal Article

    Landau, H. J.; Orlando, E.; Rodriguez, E. S.; Applebaum, A.; Mitchell, H. R.; Peled, J. U.; Khan, N.; Funnell, T.; Chung, D.; Scordo, M.; more...
    Transplantation and Cellular Therapy (2022)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, H. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Characteristics and impact of post-transplant interdisciplinary palliative care consultation in older allogeneic hematopoietic cell transplant recipients
    Journal Article

    Lin, R. J.; Cohen, A. G.; Stabler, S. M.; Devlin, S. M.; Elko, T. A.; Maloy, M. A.; Korc-Grodzicki, B.; Alexander, K.; Kramer, D.; Sanchez-Escamilla, M.; more...
    Journal of Palliative Medicine (2020)

    Fulltext@MSK | Save
  • Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
    Journal Article

    Sermer, D.; Batlevi, C.; Lia Palomba, M.; Shah, G.; Lin, R. J.; Perales, M. A.; Scordo, M.; Dahi, P.; Pennisi, M.; Afuye, A.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • Impact and safety of chimeric antigen receptor T cell therapy in vulnerable older patients with relapsed/refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, J. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save